共 65 条
[1]
Bilezikian JP(2018)Hyperparathyroidism Lancet 391 168-178
[2]
Bandeira L(2009)Hyperparathyroidism Lancet 374 145-158
[3]
Khan A(2015)Health state utilities associated with major clinical events in the context of secondary hyperparathyroidism and chronic kidney disease requiring dialysis Health Qual Life Outcomes 13 90-440
[4]
Fraser WD(2012)Mineral and bone disorders in chronic kidney disease: new insights into mechanism and management Ann Clin Biochem 49 432-322
[5]
Davies EW(2003)Parathyroid adenomas and cardiovascular risk Endocr Relat Cancer 10 303-25
[6]
Matza LS(2013)Assessing risk in chronic kidney disease: a methodological review Nat Rev Nephrol 9 18-968
[7]
Worth G(2016)The American association of endocrine surgeons guidelines for definitive management of primary hyperparathyroidism JAMA Surg 151 959-840
[8]
Lewis R(2019)Comparison of ultrasound-guided percutaneous microwave ablation and parathyroidectomy for primary hyperparathyroidism Int J Hyperthermia 36 835-18
[9]
de la Torre NG(2019)Thermal ablation versus parathyroidectomy for secondary hyperparathyroidism: a meta-analysis Int J Surg 70 13-3618
[10]
Wass JA(2014)Medical management of primary hyperparathyroidism: proceedings of the fourth international workshop on the management of asymptomatic primary hyperparathyroidism J Clin Endocrinol Metab 99 3607-3569